DUBLIN, Dec 9, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Women's Health Diagnostics Market - Forecast to 2021" report to their offering.
Growth in this market can be attributed to a number of factors such as high prevalence of infectious diseases in women, rising incidence of chronic and lifestyle-related disorders and increasing awareness about fertility testing in women and initiatives taken by government and health organizations.
Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, high cost of diagnostic solutions and lack of trained laboratory technicians are some of the factors restraining the growth of this market.
The women health diagnostics market in this report is segmented by application and end users. Based on application, the market is segmented into osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound.
In 2015, North America accounted for the largest share to the global women health diagnostics market, followed by Europe, Asia-Pacific, and the RoW. Growth in the North American market is largely driven by the increasing prevalence of cancer among women in this region, the presence of a large number of players and their increasing efforts to expand presence in North America.
- Abbott Laboratories
- Alere Inc.
- Becton, Dickinson and Company
- Biomérieux SA
- F. Hoffmann-La Roche AG
- GE Healthcare
- Hologic, Inc.
- Koninklijke Philips N.V.
- Perkinelmer Inc.
- Quest Diagnostics Inc.
- Siemens AG
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Women's Health Diagnostics Market, by Application
8 Women's Health Diagnostics Market, by End User
9 Women's Health Diagnostics Market, by Region
10 Competitive Landscape
11 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/6zdctf/womens_health
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-womens-health-diagnostics-market---high-prevalence-of-infectious-diseases-in-women---research-and-markets-300375983.html
SOURCE Research and Markets